zinacef powder for solution for injection
acs dobfar s.p.a - cefuroxime (cefuroxime sodium) - powder for solution for injection - 750mg
zinacef injection 750mg
glaxosmithkline pharmaceutical sdn. bhd. - cefuroxime sodium -
zinacef injection 1.5g
glaxosmithkline pharmaceutical sdn. bhd. - cefuroxime sodium -
toff plus capsules capsules, hard
panacea biotec pharma limited (unit-1), india - dextromethorphan - capsules, hard - 15mg+2mg+10mg+500mg
mycept-s 180 tablets
panacea biotec pharma limited, india - mycophenolate sodium - tablets - 180
prasugrel tablet, film coated
panacea biotec limited - prasugrel hydrochloride (unii: g89jq59i13) (prasugrel - unii:34k66tbt99) - prasugrel 5 mg - prasugrel tablet is indicated to reduce the rate of thrombotic cardiovascular (cv) events (including stent thrombosis) in patients with acute coronary syndrome (acs) who are to be managed with percutaneous coronary intervention (pci) as follows: - patients with unstable angina (ua) or non-st-elevation myocardial infarction (nstemi). - patients with st-elevation myocardial infarction (stemi) when managed with primary or delayed pci. prasugrel tablet has been shown to reduce the rate of a combined endpoint of cardiovascular death, nonfatal myocardial infarction (mi), or nonfatal stroke compared to clopidogrel. the difference between treatments was driven predominantly by mi, with no difference on strokes and little difference on cv death [see clinical studies (14)] . prasugrel tablet is contraindicated in patients with active pathological bleeding such as peptic ulcer or intracranial hemorrhage [see warnings and precautions (5.1) and adverse reactions (6.1)] . prasugrel tablet is contraindicated in patients wit
finace film-coated tablet
aceclofenac bp - film-coated tablet - 100 mg - aceclofenac
finace plus film-coated tablet
aceclofenac bp & paracetamol bp - film-coated tablet - aceclofenac 100 mg & paracetamol 500 mg - aceclofenac
finace mr tablet
medisel kenya limited factory street, p.o.box 540, thika-01000, - aceclofenac, paracetamol and chlorzoxazone - tablet - each tablet contains :aceclofenac 100 mg, - non-steroidal
mmf-panacea biotec
interpharma (nz) ltd - mycophenolate mofetil 250mg - capsule - 250 mg - active: mycophenolate mofetil 250mg excipient: croscarmellose sodium gelatin indigo carmine iron oxide red iron oxide yellow magnesium stearate povidone purified water starch titanium dioxide - prophylaxis of acute organ rejection in patients receiving allogeneic renal transplants. prophylaxis of acute organ rejection in patients receiving allogeneic cardiac transplants. in the treated population, mmf improved survival in the first year after transplantation. prophylaxis of acute organ rejection in patients receiving allogeneic hepatic transplants.